Turner Investments’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Turner Investments’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-24,783	Closed	-$83K	–	262
2017 Q2	$83K	Sell	24,783 -13,300	-35%	-$55.2K	0.05%	228
2017 Q1	$351K	Hold	38,083	–	–	0.23%	135
2016 Q4	$294K	Sell	38,083 -57,660	-60%	-$530K	0.12%	198
2016 Q3	$1.09M	Buy	95,743 +1,933	+2%	+$22.5K	0.36%	96
2016 Q2	$1.16M	Buy	+93,810	New	+$1.14M	0.36%	85

Other funds holding OMED

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Turner Investments's OMED Position: Q3 2017 in Review

Turner Investments sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q3 2017, closing a stake of 24,783 shares — an estimated $83K sold.

Turner Investments first reported a position in OMED in Q2 2016 and held it in 5 quarters. The position peaked at $1.16M in Q2 2016. 58 funds tracked by Wall St. Rank hold OMED as of Q3 2017.

Turner Investments reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
Turner Investments sold 24,783 OncoMed Pharmaceuticals, Inc. shares in Q3 2017, an estimated $83K.
Turner Investments first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2016 and held it in 5 quarters.
Turner Investments's OncoMed Pharmaceuticals, Inc. position peaked at $1.16M in Q2 2016.
58 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q3 2017.

Based on Turner Investments's 13F filing for Q3 2017, filed 8 Nov 2017.